intestinal microbiota

Cell therapyexperimental

Gut microbiota, gut microbiome, or gut flora are the microorganisms, including bacteria, archaea, fungi, and viruses, that live in the digestive tracts of animals. The gastrointestinal metagenome is the aggregate of all the genomes of the gut microbiota. The gut is the main location of the human microbiome. The gut microbiota has broad impacts, including effects on colonization, resistance to pathogens, maintaining the intestinal epithelium, metabolizing dietary and pharmaceutical compounds, controlling immune function, and even behavior through the gut–brain axis. — Wikipedia

Clinical trial activity

3 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1

Earliest trial started Oct 1, 2014 (NCT02857582)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • intestinal microbiota

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06931808Phase 4Mar 1, 2025Ningbo University
NCT02301000N/ANov 1, 2014Osaka University, University of Oslo
NCT02857582Phase 2Oct 1, 2014Karolinska Institute, Uppsala University
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Karolinska InstituteAcademic/Hospital1012014
Ningbo UniversityAcademic/Hospital1112025
Osaka UniversityAcademic/Hospital1112014
University of OsloAcademic/Hospital1012014
Uppsala UniversityAcademic/Hospital1112014
5 organizations
Page 1 / 1